You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Idarubicin

Showing 51 - 75 of 319
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Liver Cancer Trial in France (idarubicin, Dc- Beads 300-500µm)

Completed
  • Liver Cancer
  • idarubicin
  • Dc- Beads 300-500µm
  • Amiens, France
  • +6 more
Mar 27, 2020

Acute Myeloid Leukemia Trial in Boston (Alisertib, Cytarabine, Idarubicin)

Completed
Has Results
  • Acute Myeloid Leukemia
  • Boston, Massachusetts
  • +1 more
Apr 23, 2020

Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic

Completed
Has Results
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • +16 more
  • choline magnesium trisalicylate
  • +3 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Aug 20, 2021

Leukemia, Myeloid, Acute Trial in Spain (Idarubicin, Ara-C, G-CSF)

Recruiting
  • Leukemia, Myeloid, Acute
  • Idarubicin
  • +5 more
  • Badalona, Barcelona, Spain
  • +14 more
Jul 30, 2021

Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Durham (Idarubicin, Cytarabine, DLI)

Completed
Has Results
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome
  • Idarubicin
  • +2 more
  • Durham, North Carolina
    Duke University Medical Center
Dec 1, 2020

Acute Myeloid Leukemia Trial in United States (CX-01, Idarubicin, Cytarabine)

Completed
Has Results
  • Acute Myeloid Leukemia
  • La Jolla, California
  • +22 more
Sep 30, 2021

Acute Myeloid Leukemia Trial in France (Cytarabine and Idarubicin, CPX-315)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Amiens, France
  • +29 more
Apr 8, 2022

Novo Acute Myeloid Leukemia Trial in Spain (Mylotarg)

Completed
Has Results
  • Novo Acute Myeloid Leukemia
  • Badalona, Barcelona, Spain
  • +5 more
Jan 26, 2021

Acute Myeloid Leukemia Trial in Houston (Crenolanib besylate, Idarubicin, Cytarabine)

Completed
  • Acute Myeloid Leukemia
  • Crenolanib besylate
  • +7 more
  • Houston, Texas
    MD Anderson Cancer Center
Jul 17, 2020

Acute Myeloid Leukemia Trial in Poland, United States (A arm (DA-90), B arm (DAC), A arm (CLAG-M))

Recruiting
  • Acute Myeloid Leukemia
  • A arm (DA-90)
  • +3 more
  • New York, New York
  • +9 more
Sep 30, 2021

Acute Lymphoid Leukemia Trial in Seoul (Blincyto)

Not yet recruiting
  • Acute Lymphoid Leukemia
  • Seoul, Gangnam-gu, Korea, Republic of
  • +4 more
Apr 12, 2023

Acute Myeloid Leukemia Trial in Spain (Quizartinib, Fludarabine, Cytarabine)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Alicante, Spain
  • +19 more
Mar 11, 2022

AML in Remission Trial in Fuzhou (Idarubicin, ID cytarabine)

Recruiting
  • AML in Remission
  • Idarubicin
  • ID cytarabine
  • Fuzhou, Fujian, China
    Fujian Medical University Union Hospital
Jan 1, 2020

Acute Myeloid Leukemia (AML) Trial in Germany, Spain, United States (Panobinostat)

Completed
  • Acute Myeloid Leukemia (AML)
  • Stanford, California
  • +9 more
Dec 16, 2020

Soft Tissue Sarcoma Trial in Worldwide (trofosfamide, idarubicin, etoposide)

Active, not recruiting
  • Soft Tissue Sarcoma
  • trofosfamide, idarubicin, etoposide
  • Graz, Austria
  • +73 more
Nov 12, 2021

Leukemia Trial in Houston (LY2510924, Idarubicin, Cytarabine)

Completed
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Nov 14, 2019

Acute Myeloid Leukemia Trial in NanJing (Homoharringtonine, Azacitidine)

Recruiting
  • Acute Myeloid Leukemia
  • NanJing, China
    Department of Hematology, Zhongda Hospital, Medical School of So
Sep 2, 2022

Acute Myeloid Leukemia (AML) Trial in France (Idarubicin, Daunorubicin, HD Cytarabine)

Recruiting
  • Acute Myeloid Leukemia (AML)
  • Idarubicin
  • +9 more
  • Amiens, France
  • +54 more
Oct 16, 2020

Acute Myeloid Leukemia, in Relapsed or Refractory, Acute Myeloid Leukemia, Elderly, Unfit, Acute Myeloid Leukemia With Positive

Unknown status
  • Acute Myeloid Leukemia, in Relapsed or Refractory
  • +2 more
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Sep 8, 2020

T-lymphoblastic Lymphoma, Relapsed Disease, Refractory Lymphoma Trial in Shanghai (BCL2 Inhibitor plus IM2 regimen)

Recruiting
  • T-lymphoblastic Lymphoma
  • +5 more
  • BCL2 Inhibitor plus IM2 regimen
  • Shanghai, Shanghai, China
    Shanghai General hospital,Shanghai Jiao Tong University School o
Jan 10, 2023

Autologous Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia, Conditioning Trial in Guangzhou (Idarubicin(IDA),

Completed
  • Autologous Hematopoietic Stem Cell Transplantation
  • +2 more
  • Guangzhou, Guangdong, China
    Department of Hematology,Nanfang Hospital, Southern Medical Univ
Mar 2, 2020

Leukemia Trial in United States (cytarabine, idarubicin, pravastatin sodium)

Active, not recruiting
Has Results
  • Leukemia
  • Birmingham, Alabama
  • +184 more
Feb 4, 2022

Acute Myeloid Leukemia (AML) Trial in Austria, Germany (Dasatinib, Cytarabine, Daunorubicin)

Active, not recruiting
  • Acute Myeloid Leukemia (AML)
  • Innsbruck, Austria
  • +53 more
Sep 19, 2022

Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia-2, High Risk Myelodysplastic Syndrome Trial in New Haven, Baltimore,

Completed
  • Acute Myeloid Leukemia
  • +3 more
  • New Haven, Connecticut
  • +2 more
Oct 10, 2020

Acute Myeloid Leukemia Trial in Spain (Selinexor, fludarabine, idarubicin)

Completed
  • Acute Myeloid Leukemia
  • Badalona, Spain
  • +3 more
May 19, 2020